Merkel cell carcinoma and cherry angiomas can both present as small, reddish or violaceous bumps on the skin, but they sit at opposite ends of the danger spectrum. Cherry angiomas are the most common vascular skin growths in adults and are entirely benign. Merkel cell carcinoma is a rare, aggressive skin cancer with a significant mortality rate. The clinical overlap between the two is narrow but real enough that researchers have studied their color profiles side by side, and a bump that looks harmless can occasionally turn out to be something far more serious.
Why These Two Get Compared at All
At first glance, the comparison seems strange. One is a cancer most people have never heard of; the other is a spot nearly every adult develops sooner or later. Cherry angiomas are the most common vascular tumors of the skin, becoming more frequent with age, and most people over 40 have at least a few.1Actas Dermo-Sifiliográficas. Clinical Relevance of Cherry Angiomas Merkel cell carcinoma is diagnosed roughly 3,000 times per year in the United States. The reason they end up in the same conversation is appearance: both can show up as a firm, dome-shaped, reddish nodule on sun-exposed skin in older adults. Dermatologists sometimes note that early-stage Merkel cell carcinoma is mistaken for a cyst, an insect bite, or a benign vascular lesion like a cherry angioma, which can delay biopsy.
A 2024 color-analysis study directly compared the two. Researchers found that Merkel cell carcinoma and cherry angiomas differ measurably in their blue color channel and in a specific color parameter that captures how blue or yellow a lesion appears. The differences were statistically clear, suggesting that even standardized photography might help separate the two.2PubMed Central. Color Analysis of Merkel Cell Carcinoma: A Comparative Study with Cherry Angiomas, Hemangiomas, Basal Cell Carcinomas, and Squamous Cell Carcinomas – Section: 3. Results In practical terms, cherry angiomas tend to be a bright, well-defined red, while Merkel cell carcinoma more often has a pinkish, violaceous, or dusky quality with less uniform coloring.
What Cherry Angiomas Look and Feel Like
Cherry angiomas are small, bright-red to dark-red papules, usually a few millimeters across, though they can grow to a centimeter or more. They feel smooth and dome-shaped, and pressing on them may cause them to blanch partially. The trunk is the most common location, particularly the front of the torso, followed by the back.3PubMed. Anatomic Distribution of Cherry Angiomas in the General Population – Section: RESULTS They also appear on the arms, legs, and occasionally the face, though they tend to spare the hands, feet, and mucous membranes.
Their numbers increase with age, and men tend to develop more of them than women. In one large study, men had a median of 16 angiomas compared with 12 in women, and an increase was associated with fair skin, Caucasian ancestry, and green or hazel eyes. Interestingly, although men had more angiomas overall, women had more on their legs.4PubMed. Anatomic Distribution of Cherry Angiomas in the General Population – Section: RESULTS A personal history of melanoma was also associated with having more cherry angiomas, though this does not mean cherry angiomas themselves become melanoma. The association likely reflects shared skin-type risk factors.
Cherry angiomas do not hurt, itch, or bleed unless you physically traumatize them. They do not transform into cancer. They are made up of clusters of dilated capillaries in the upper layer of the dermis, and laboratory studies show that their lining cells are actively proliferating, which explains why the spots grow over time. Those endothelial cells also express a protein called WT1, which has been proposed as a marker of active blood-vessel growth.5PubMed. Campbell de Morgan Spots (Cherry Angiomas) Show Endothelial Proliferation Despite that proliferative activity, the growth is entirely controlled and benign.
What Merkel Cell Carcinoma Looks and Feels Like
Merkel cell carcinoma typically appears as a firm, painless, rapidly growing nodule. The color ranges from red to violaceous to skin-colored, and the surface is often shiny and smooth. It favors sun-exposed areas, especially the head and neck, though it can appear on the extremities or trunk. It is most common in people over 50, in those with fair skin, and in individuals whose immune systems are compromised.
A useful clinical mnemonic, AEIOU, captures the pattern seen in most cases: asymptomatic (not tender), expanding rapidly, immune suppression, older than 50, and ultraviolet-exposed site on a person with fair skin. In a study of 195 patients, 89% of primary Merkel cell carcinomas had three or more of those features at diagnosis.6PubMed Central. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features – Section: CONCLUSIONS The AEIOU checklist is meant to help clinicians recognize when a suspicious bump warrants a biopsy. It is not a diagnostic tool on its own, and a bump that hits only one or two criteria could still be Merkel cell carcinoma.
Rapid growth is the single most distinguishing feature from a cherry angioma. Cherry angiomas appear gradually and change slowly over months or years. A Merkel cell carcinoma nodule can double in size within weeks. If you notice a new red or violet bump that is growing noticeably from one week to the next, that pace alone is a reason to see a dermatologist quickly.
How Dermatologists Tell Them Apart Under Magnification
Dermoscopy, the technique of examining skin lesions under magnification with polarized light, reveals very different internal structures in these two lesions. Cherry angiomas show well-organized vascular lacunae, essentially small pools of blood that appear reddish-brown to reddish-blue. The vessels visible in them tend to be serpentine, coiled, looped, or curved, and occasionally a lesion will look dark or show a faint whitish veil on the surface.7PubMed Central. Dermoscopic Features Summarization and Comparison of Four Types of Cutaneous Vascular Anomalies – Section: Results The overall pattern is regular and repetitive, which signals benignity.
Merkel cell carcinoma looks very different under the dermatoscope. The hallmark is a polymorphous vascular pattern, meaning multiple different vessel types coexist within the same lesion: linear irregular vessels, branching tree-like vessels, glomerular (coiled cluster) vessels, and tiny dotted vessels, all set against a milky-red or milky-pink background. Shiny white areas and structureless zones are also common. About 40% of cases in one study showed the polymorphous vessel pattern.8PubMed Central. Dermoscopic characteristics of Merkel cell carcinoma – Section: Results Poorly focused vessels and architectural disorder further distinguish it from benign vascular lesions.9PubMed. Clinical and dermoscopic characteristics of Merkel cell carcinoma – Section: RESULTS
The practical takeaway: a dermatologist looking through a dermatoscope at a cherry angioma will see a tidy, repetitive blood-vessel pattern. Looking at a Merkel cell carcinoma, they will see chaos. The disorganized mix of vessel types, the milky background, and the structureless zones all raise a red flag that this is not a simple benign growth.
What Causes Each One
Cherry angiomas have no single established cause. They are considered part of normal skin aging. Their endothelial cells proliferate and form dilated capillary clusters, but no virus, carcinogen, or genetic mutation has been pinpointed as the trigger. Some research has linked chemical exposures (like bromides or certain industrial solvents) to outbreaks of cherry angiomas, but for the vast majority of people they simply accumulate with time.
Merkel cell carcinoma has two distinct pathways. Roughly 80% of cases are driven by a virus called Merkel cell polyomavirus, which integrates its DNA into the tumor genome. These virus-positive tumors have relatively few other genetic mutations. The remaining 20% of cases are virus-negative and instead carry a heavy load of mutations caused by ultraviolet radiation damage.10PubMed Central. Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome Both types are aggressive, but the distinction matters for treatment because virus-positive tumors display viral proteins on their surface that the immune system can potentially target, while UV-driven tumors have many mutations that generate a different set of targets for immunotherapy.
Immune suppression plays an outsized role in Merkel cell carcinoma. People who have undergone organ transplants, who are living with HIV, or who are on long-term immunosuppressive medications develop Merkel cell carcinoma at dramatically higher rates. One retrospective study found that immunosuppression was the only AEIOU criterion that was significantly associated with disease progression, outweighing age, UV exposure, and the other clinical features.11PubMed Central. Immunosuppression Outweighs Clinical AEIOU Heuristics in Predicting Disease Progression of Merkel Cell Carcinoma: A Retrospective Cohort Study Cherry angiomas, by contrast, show no meaningful link to immune status.
Confirming the Diagnosis
Cherry angiomas rarely need a biopsy. A dermatologist can usually identify one by sight or with dermoscopy. When a cherry angioma is biopsied (sometimes because it has an unusual appearance or was removed for cosmetic reasons), the pathologist sees dilated capillary vessels in the upper dermis, filled with red blood cells. In rare instances, an unexpected finding can emerge from what looked like a simple cherry angioma. One case report described a biopsy of what appeared to be a cherry angioma that instead revealed a blood-vessel cancer (intravascular large B-cell lymphoma), with large abnormal lymphoid cells filling the dilated vessels.12PubMed Central. Intravascular large B‑cell lymphoma diagnosed by skin biopsy from cherry angioma: A case report That is an extraordinarily rare event, but it underscores that any skin lesion with atypical features deserves closer inspection.
Merkel cell carcinoma, on the other hand, always requires biopsy and a specific set of laboratory stains to confirm. Under the microscope, it appears as sheets of small, round blue cells that can resemble other aggressive cancers like small-cell lung cancer or lymphoma. To sort it out, pathologists use a panel of antibody stains. The majority of Merkel cell carcinomas express a protein called cytokeratin 20 (CK20) in a distinctive dot-like pattern and are negative for cytokeratin 7 (CK7). Additional markers like epithelial membrane antigen and neuron-specific enolase help confirm the diagnosis.13PubMed Central. Merkel cell carcinoma with an unusual immunohistochemical profile Without these stains, Merkel cell carcinoma can be confused with other small-round-blue-cell tumors, which is one reason delayed or incorrect diagnosis sometimes occurs.
Staging and Spread of Merkel Cell Carcinoma
Cherry angiomas do not spread. They do not invade deeper tissue or travel to lymph nodes. No staging system exists for them because there is nothing to stage.
Merkel cell carcinoma behaves very differently. It has a high rate of regional lymph-node involvement even when the primary tumor looks small and localized. Sentinel lymph node biopsy, a procedure where the first draining lymph node is identified and tested for cancer cells, is commonly performed for staging. In a meta-analysis of sentinel-node data, about a third of patients whose tumors appeared clinically localized turned out to have microscopic cancer in their sentinel node. Those patients had a three-year recurrence rate of 60%, compared with 20% for those with a negative sentinel node.14Archives of Dermatology. Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients With Merkel Cell Carcinoma: The Dana-Farber Experience and Meta-analysis of the Literature – Section: Results
A large multi-institutional study of nearly 500 patients reinforced the value of sentinel-node biopsy. Among those who underwent the procedure, about 34% had a positive node. After adjusting for patient differences, sentinel-node biopsy was associated with roughly half the risk of regional recurrence compared with observation alone, and improved overall survival.15Journal of Clinical Oncology. Sentinel lymph node biopsy in Merkel cell carcinoma: A multi-institutional study from the Pan-Canadian Merkel Cell Collaborative. This is why guidelines strongly recommend sentinel-node biopsy for most Merkel cell carcinoma patients, even when the primary tumor seems small and contained.
How Each Is Treated
Cherry angiomas do not need treatment unless they bother you cosmetically or bleed from repeated friction. When people do want them removed, several options work well. A systematic review found that laser therapy and non-laser methods like cryotherapy, electrosurgery, and radiofrequency ablation all effectively clear cherry angiomas, with no single approach proving definitively superior.16PubMed. Treatment Modalities for Cherry Angiomas: A Systematic Review – Section: RESULTS Among lasers, pulsed dye laser caused less pain than other laser types or electrodesiccation and produced better skin texture afterward.17JAMA Dermatology. Comparison of Treatment of Cherry Angiomata With Pulsed-Dye Laser, Potassium Titanyl Phosphate Laser, and Electrodesiccation: A Randomized Controlled Trial – Section: Results For people with darker skin tones, certain lasers carry a higher risk of pigmentation changes, so the choice of device matters. Treatment often requires more than one session.18PubMed. Laser treatment of pigmented and vascular lesions in the office
Merkel cell carcinoma treatment is far more involved. For localized disease, the standard approach is wide surgical excision of the primary tumor, often with sentinel-node biopsy and adjuvant radiation to reduce the risk of local recurrence. If sentinel nodes are positive, additional nodal treatment with surgery, radiation, or both follows.
For advanced disease that has spread beyond the region or cannot be surgically removed, immunotherapy with checkpoint inhibitors has transformed outcomes. Drugs like pembrolizumab and avelumab, which release the brakes on the immune system’s ability to recognize and attack cancer cells, have become the first-line treatment for advanced Merkel cell carcinoma.19Journal for ImmunoTherapy of Cancer. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma Response rates to immunotherapy are encouraging, and the virus-driven nature of many Merkel cell carcinomas makes them particularly visible to immune cells. However, not all patients respond, and those who are immunosuppressed (the very group most at risk for the cancer) tend to have lower response rates to immunotherapy, creating a difficult clinical paradox.
When a Red Bump Deserves a Closer Look
Most red bumps on the skin of a middle-aged or older adult are cherry angiomas, and most of the time, ignoring them is perfectly reasonable. But a few features should prompt you to get a professional opinion rather than assuming the spot is benign:
- Rapid growth: A bump that visibly enlarges over days to weeks, rather than staying stable or growing imperceptibly over months.
- Unusual color: A pinkish, violaceous, or dusky tone rather than the bright cherry-red of a typical angioma.
- Firmness: A hard or rubbery feel, different from the soft, slightly compressible texture of a cherry angioma.
- Pain or tenderness: Cherry angiomas are painless. A bump that aches or is tender to touch deserves investigation, though Merkel cell carcinoma is also usually painless.
- Immune status: If you are on immunosuppressive medications, have had an organ transplant, or have another reason for a weakened immune system, the threshold for getting a new skin bump checked should be lower.
None of these features alone means cancer. Plenty of benign conditions produce firm, fast-growing, or oddly colored bumps. The point is that the cost of a dermatologist visit and possible biopsy is trivial compared with the cost of catching an aggressive cancer late.
Emerging Tools for Non-Invasive Assessment
Beyond dermoscopy, newer imaging technologies are being explored to characterize skin lesions without cutting into them. Optical coherence tomography, which uses light waves to create cross-sectional images of skin structures in real time, has been applied to vascular lesions. In studies of various skin growths, it has been able to visualize blood-vessel proliferation from the outermost skin layer down into the dermis, with the images correlating well to what would be seen under a microscope after biopsy.20PubMed. Application of optical coherence tomography in non-invasive characterization of skin vascular lesions – Section: RESULTS The color-analysis research comparing Merkel cell carcinoma to cherry angiomas using standardized photography represents another angle. If digital tools can reliably flag which reddish bumps have the color signature of something more worrisome, they could help triage patients for biopsy more efficiently, particularly in primary care settings where dermoscopy expertise may be limited.
Skin cancer detection is expensive. One health-system analysis estimated that the cost per melanoma detected through dermatology screening was roughly $33,000.21PubMed Central. Estimating the cost of skin cancer detection by dermatology providers in a large healthcare system – Section: Results Merkel cell carcinoma is far rarer than melanoma, so the cost per case detected would be much higher if you were screening for it specifically. Tools that improve pre-biopsy accuracy, whether through artificial intelligence analysis of clinical photos, dermoscopic pattern recognition, or novel imaging, could make detection more practical for rare cancers that mimic common benign lesions.